Sensitization

Sensitization is a process in which repeated exposure to a stimulus — a drug, a stressor, or an environmental cue — produces a progressively larger response rather than a diminishing one. It runs in the opposite direction to tolerance, and crucially, the two can operate at the same time in different neural circuits.

The phenomenon has been studied most thoroughly with stimulant drugs, where it is often called behavioral sensitization or locomotor sensitization — names drawn from how it is measured in laboratory animals: repeated injections of amphetamine or cocaine produce ever-larger bursts of movement, even when the dose stays fixed.

How it works · its role

The core mechanism sits in the mesolimbic dopamine system — the pathway running from the ventral tegmental area to the nucleus accumbens and prefrontal cortex. Repeated stimulant exposure appears to sensitize dopamine release in this circuit: each subsequent exposure drives a larger dopamine surge than the last.

Underlying this are lasting structural changes. Neurons in the nucleus accumbens grow more dendritic spines; AMPA-type glutamate receptors redistribute to the synapse surface. A transcription factor called ΔFosB accumulates with each exposure and persists for weeks, acting as a kind of molecular record of prior drug history that keeps the circuit primed.

The sensitized state can lie dormant for long stretches. A stressor, an environmental cue linked to past use, or even a small priming dose can reinstate it — which is part of why relapse risk does not simply diminish with abstinence time.

Relevance to substances & effects

Stimulants are the clearest example. Cocaine, amphetamine, and methamphetamine all produce robust behavioral sensitization in animal models, and the dopaminergic neuroplasticity involved is thought to contribute to compulsive patterns of use in humans.

Cross-sensitization is well documented: repeated exposure to one stimulant can lower the threshold for sensitization to another, and certain stress protocols sensitize animals to drug effects without any prior drug exposure at all.

Classic psychedelics present an instructive contrast — they do not sensitize; they produce rapid, marked tolerance that clears within days. The difference in receptor mechanisms (5-HT₂A downregulation versus dopaminergic potentiation) is one reason psychedelic use tends not to escalate into compulsive daily patterns the way stimulant use can.

Tolerance & dependence

The most consequential feature of sensitization is the dissociation it can create between wanting and liking. Tolerance tends to blunt the pleasurable, hedonic quality of a drug — the euphoric high fades with repeated use. Sensitization, acting in a different circuit, may simultaneously strengthen the motivational pull: the craving, the compulsive drive to seek and use.

This framework helps explain a pattern that puzzles many people, including users themselves: continued, escalating pursuit of a drug even when it no longer reliably produces pleasure.

The wanting system has been sensitized; the liking system has been blunted by tolerance. Sensitization, in this account, is not just a pharmacological curiosity but a mechanism by which use can become self-sustaining even in the absence of reinforcing euphoria.